“I’m honored and humbled that Second Genome has been acknowledged as a pioneer by the World Economic Forum,” said Glenn Nedwin, Ph.D., president and chief executive officer of Second Genome.
Second Genome, Inc., a leader in the development of novel medicines through innovative microbiome science, announced today, the company was selected among hundreds of candidates as one of the World Economic Forum’s “technology pioneers,” a selection of the world’s most innovative companies.
“I’m honored and humbled that Second Genome has been acknowledged as a pioneer by the World Economic Forum,” said Glenn Nedwin, Ph.D., president and chief executive officer of Second Genome. “It is a privilege to be among other amazing leaders as we give ourselves to lead a paradigm shift in science and medicine, and produce new products for health and wellness by harnessing the immense power of the human microbiome.”
Dr. Nedwin will be participating in the World Economic Forum Annual Meeting of the New Champions. This meeting, also dubbed “Summer Davos” will be held in Dalian, China, June 27-29. Many Pioneers will also attend the Annual Meeting in Davos, in January 2018, and continue to participate in dedicated Technology Pioneer community events in the course of the next two years.
“We welcome Second Genome in this group of extraordinary pioneers,” says Fulvia Montresor, Head of Technology Pioneers at the World Economic Forum. “We hope that thanks to this selection, the World Economic Forum can facilitate greater collaboration with business leaders, governments, civil society and other relevant individuals to accelerate the development of technological solutions to the world’s greatest challenges.”
The World Economic Forum’s Technology Pioneers community are early-stage companies from around the world that are involved in the design, development and deployment of new technologies and innovations, and are poised to have a significant impact on business and society. The 30 technology pioneers that made it to the final selection are active in artificial intelligence, augmented reality, autonomous vehicles, biotechnology, blockchain, cybersecurity, the (industrial) internet of things, and other pioneering technologies.
The Technology Pioneers were selected by a selection committee of more than 60 academics, entrepreneurs, venture capitalists and corporate executives. Notable members of the committee include Geoffrey Moore (Adviser, Geoffrey Moore Consulting, USA), Yossi Vardi (Chairman, International Technologies, Israel) and Lee Sang-Yup (Distinguished Professor and Dean, Korea Advanced Institute of Science and Technology, Republic of Korea). The committee based its decisions on criteria including innovation, potential impact and leadership. Past recipients include Airbnb, Google, Kickstarter, Mozilla, Palantir Technologies, Scribd, Spotify, Twitter and Wikimedia.
All info on this year’s Technology Pioneers can be found here: http://wef.ch/techpioneers17
More information on past winners can be found here.
About Second Genome
Second Genome’s mission is to transform lives with medicines developed through innovative microbiome science. Second Genome has built a novel platform for microbiome drug discovery. The company has established a pipeline of therapeutic products for the treatment of inflammation and metabolic diseases. Please visit www.secondgenome.com for more information.
About World Economic Forum
The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation. The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. (www.weforum.org).